The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...

Jury selection in Cook County is set to kick off this week in a closely watched courtroom battle over Abbott Laboratories’ ...

A trial is set to begin on Wednesday in Chicago in a case brought by four families who allege that baby ​formula made by Abbott Laboratories caused their premature infants to develop a dangerous bowel ...

Abbott is an innovator and has made plenty of highly successful breakthroughs. That's what it did with its FreeStyle Libre ...

Abbott Laboratories Inc. defeated a proposed class action alleging it disclosed the protected health data of consumers to ...

Abbott Labs is looking to raise about $20 billion from a bond sale to help fund its acquisition of Exact Sciences, marking one of the biggest offerings this year.

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund ...

Recent performance snapshot Abbott Laboratories (ABT) has seen mixed share performance recently, with a modest 0.2% move over ...

Abbott Laboratories has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

Abbott Laboratories is delivering double-digit percentage earnings growth along with a dependable dividend.

Abbott stock skidded Wednesday after the S&P 500 health giant missed the Street's third-quarter sales forecast, but met earnings expectations and reiterated its full-year guidance. The sales miss is ...

The stock's fall snapped a three-day winning streak.